Our Mission Starts Here
Our culture of innovation, excellence, and leadership starts with our executive team and is embodied by every member of our company.
Meet our Leadership Team
Arul M. Chinnaiyan, MD, PhD
Founder
Arul M. Chinnaiyan, MD, PhD
Founder
With a focus on improving prostate cancer screening, Arul M. Chinnaiyan founded Lynx Dx. Dr. Chinnaiyan is a S.P. Hicks Professor of Pathology and Urology at Michigan Medicine and serves as the inaugural Director at the Michigan Center for Translational Pathology. Most recently, he was awarded the 2022 Sjöberg Prize for his discovery of TMPRSS2:ERG, the fusion gene responsible for more than half of all prostate cancer cases, and has received numerous other awards for his research.
Steve Riggs, MBA
President
Steve Riggs, MBA
President
Steve Riggs is the President of Lynx Dx. Mr. Riggs is a highly accomplished, results-oriented executive leader with decades of experience directing financial and administrative operations. He has a proven track record of consistently identifying complex business issues and implementing successful solutions to improve patient outcomes and experience.
Spencer Heaton, MD, MBA
Chief Medical Officer
Spencer Heaton, MD, MBA
Chief Medical Officer
Spencer Heaton is the Chief Medical Officer of Lynx Dx. Dr. Heaton is a physician executive with decades of experience in healthcare delivery, healthcare technology services, and medical research. Dr. Heaton has an established reputation for using new technologies to create outcome improvements in medical device surveillance and pharmacovigilance.
Mark Willig
Chief Commercial Officer
Mark Willig
Chief Commercial Officer
Mark is an executive leader in the life sciences space with over 25 years of successful c-suite experience in building, restructuring, and turning organizations around. He is a strong business leader who has built global businesses driving exponential growth using market data and analytics to exceed the expectations of Wall Street, the Board of Directors and shareholders. He has vast experience in successfully launching new product offerings at companies such as Myriad Genetics where he was the first Chief Commercial Officer, Prognostix, as CEO, Agendia BV and CardioDx as the Chief Commercial Officer. He has brought his successful management style to Fortune 100 companies such as Thermo Fisher Scientific and Abbott Laboratories. He has led three companies to acquisition, including early stage companies. Today, he serves on three Boards and was recently the CEO at Key Proteo prior to joining Lynx Dx.
Matt Martin, MBA
Chief Financial Officer
Matt Martin, MBA
Chief Financial Officer
Matt Martin serves as both the Chief Financial Officer of Lynx Dx and the Founder and President of CFO Group. He’s assisted organizations with all aspects of finance, operating and accounting issues, providing or supplementing expertise or assisting during peak periods. He has taken over operational focus for clients, and has experience implementing and operating various systems. Matt has deep experience in strategy, M&A, investor relations, and capital management.
Jeff Crays, MS
Chief Technology Officer
Jeff Crays, MS
Chief Technology Officer
Jeff Crays is the Chief Technology Officer of Lynx Dx. In this role, Mr. Crays leads technology strategies, leveraging twenty years of experience with emerging technology and business strategy. His focus has been on improving the quality of the organization’s processes, products, services, and software. Mr. Crays is an exceptional leader with an established reputation for transforming organizations into customer-facing partners and raising collaboration and trust levels while executing the long-term vision of technology investments.
John Kitchen, PhD, HCLD
Medical Director
John Kitchen, PhD, HCLD
Medical Director
Dr. John Kitchen is the Medical Director of Lynx Dx and oversees the overall operation and administration of the laboratory. Dr. Kitchen led the laboratory’s successful application to obtain CLIA and CAP accreditation and is responsible for ensuring that accreditation is maintained. He is instrumental in developing the validation and commercialization of new tests for Lynx Dx. Dr. Kitchen has a passion for guiding laboratory personnel and ensuring the accuracy of laboratory testing.
Jacob Meyers, PhD
Director, Research & Development
Jacob Meyers, PhD
Director, Research & Development
Dr. Jacob Meyers is the Director of Research and Clinical Sciences at Lynx Dx, where he leads product development, product transfer, and clinical laboratory operations. He
earned his PhD in biomedical sciences and molecular genetics and has extensive
experience in molecular assay design, clinical & analytical validation, and
commercialization of advanced diagnostic technologies. His work focuses on translating
molecular innovations into robust, scalable diagnostic products that strengthen the
company’s oncology testing portfolio and laboratory capabilities. At Lynx Dx, Dr. Meyers directed the launch of MyProstateScore 2.0 (MPS2) and the development of MPS2 non-
DRE assay.
Ryan Mitton
Director, Marketing & CX
Ryan Mitton
Director of Marketing and Customer Experience
Ryan Mitton is the Director of Marketing and Customer Experience at Lynx Dx. Mr. Mitton is an executive with over 20 years of experience in global brand strategy, go-to-market execution, and customer engagement. He has led initiatives for multi-billion-dollar brands at a top 20 Fortune 500 company and is recognized for creating customer-first strategies that deliver measurable growth. At Lynx Dx, he leads all strategic marketing initiatives and ensures a seamless customer journey across all touchpoints.